Isthmus Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $474K | Hold |
1,170
| – | – | 0.06% | 144 |
|
|
2025
Q1 | $582K | Sell |
1,170
-268
| -19% | -$133K | 0.07% | 132 |
|
|
2024
Q4 | $748K | Buy |
1,438
+868
| +152% | +$452K | 0.09% | 121 |
|
|
2024
Q3 | $353K | Hold |
570
| – | – | 0.04% | 160 |
|
|
2024
Q2 | $315K | Hold |
570
| – | – | 0.04% | 162 |
|
|
2024
Q1 | $331K | Sell |
570
-2
| -0.3% | -$1.16K | 0.04% | 160 |
|
|
2023
Q4 | $304K | Hold |
572
| – | – | 0.04% | 159 |
|
|
2023
Q3 | $290K | Sell |
572
-5
| -0.9% | -$2.53K | 0.04% | 152 |
|
|
2023
Q2 | $301K | Buy |
577
+5
| +0.9% | +$2.61K | 0.04% | 149 |
|
|
2023
Q1 | $330K | Hold |
572
| – | – | 0.05% | 145 |
|
|
2022
Q4 | $315K | Hold |
572
| – | – | 0.05% | 149 |
|
|
2022
Q3 | $290K | Hold |
572
| – | – | 0.05% | 144 |
|
|
2022
Q2 | $311K | Hold |
572
| – | – | 0.06% | 127 |
|
|
2022
Q1 | $338K | Buy |
572
+2
| +0.4% | +$1.18K | 0.06% | 132 |
|
|
2021
Q4 | $380K | Hold |
570
| – | – | 0.06% | 131 |
|
|
2021
Q3 | $326K | Hold |
570
| – | – | 0.06% | 133 |
|
|
2021
Q2 | $288K | Hold |
570
| – | – | 0.05% | 135 |
|
|
2021
Q1 | $260K | Hold |
570
| – | – | 0.05% | 137 |
|
|
2020
Q4 | $265K | Hold |
570
| – | – | 0.05% | 134 |
|
|
2020
Q3 | $252K | Hold |
570
| – | – | 0.06% | 129 |
|
|
2020
Q2 | $207K | Buy |
+570
| New | +$207K | 0.05% | 137 |
|
|
2019
Q2 | – | Sell |
-64,508
| Closed | -$7.21M | – | 202 |
|
|
2019
Q1 | $7.21M | Buy |
+64,508
| New | +$7.21M | 1.76% | 24 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$15K | – | 300 |
|
|
2017
Q1 | $15K | Buy |
+100
| New | +$15K | ﹤0.01% | 239 |
|